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a Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health research institute, Vrije Universiteit Amsterdam, the Netherlands 
b Institute for International Internet Interventions for Health (i4Health), Palo Alto University, United States 
c Department of Basic, Clinical Psychology and Psychobiology, Universitat Jaume I, Castellón, Spain 
d CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN), Madrid, Spain 
e Department of Global Health and Social Medicine, Harvard Medical School, Boston, United States 
f Institute of Clinical Psychology, Leiden University, Leiden, the Netherlands 
g School of Social Welfare, University of California Berkeley, United States 
h Department of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan   
A R T I C L E  I N F O   
Keywords: 
Depression 
Major depressive disorder 
Prevention 
Cognitive behavior therapy 
Interpersonal psychotherapy 
Meta-analysis 
A B S T R A C T   
Purpose: Depressive disorders are common and have a considerable impact on patients and societies. Several 
treatments are available, but their effects are modest and reduce the burden only to a limited extent. Preventing 
the onset of depressive disorders may be one option to further reduce the global disease burden. 
Methods: We conducted a meta-analysis of randomized controlled trials in participants without a diagnosis of 
depression at baseline, who were assigned to a preventive psychological intervention, or a care-as-usual, or 
comparable control group and in which incident cases of depression at follow-up were ascertained with a 
diagnostic interview. 
Results: Our systematic searches resulted in 50 trials (14,665 participants) with relatively high quality, in high 
risk groups of all ages. The psychological interventions were mostly based on cognitive behavioral interventions. 
One year after the preventive interventions, the relative risk of developing a depressive disorder was RR = 0.81 
(95% CI: 0.72–0.91), indicating that those who had received the intervention had 19% less chance to develop a 
depressive disorder. Given the average control event rate of 30%, twenty-one people had to participate in the 
intervention to prevent one depressive disorder compared to people in the control conditions. 
Conclusions: Prevention is a promising approach to reduce the global disease burden of depression in addition to 
treatments.   
1. Introduction 
Depressive disorders are very common with more than 300 million 
people, or 4.4% of the world population affected (World Health Orga-
nisation, 2017). Depression is also the single largest contributor to 
global disability and is responsible for 7.5% of all years with disability 
worldwide (GBD 2016 Disease and Injury Incidence and Prevalence 
Collaborators, 2017; World Health Organisation, 2017). Depression is 
also associated with considerable morbidity and mortality (Cuijpers 
et al., 2014), and high economic costs (Bloom et al., 2011; Hu, 2006). 
Several treatments are available for depression, with pharmacotherapy 
and psychotherapy as first line treatments. Although these treatments 
are effective, the effects of both pharmacotherapy and psychotherapy 
are modest (Barth et al., 2013; Cipriani et al., 2018), relapse rates are 
high and a considerable group of patients do not respond to treatments 
at all (Cuijpers, Karyotaki, & Ciharova, 2020, Cuijpers et al., 2020, 
Cuijpers, Stringaris, & Wolpert, 2020). A modelling study has shown 
that available treatments can reduce the disease burden of depression on 
a population level by only one third (Andrews, Issikadis, Sanderson, 
Corry, & Lapsley, 2004), and this is only under optimal conditions, 
assuming that all people with depression are treated with an evidence- 
based treatment. In reality, the number of people receiving treatment 
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is less than 50%, even in high-income countries (Chisholm et al., 2016). 
Preventing the onset of depressive disorders could be an alternative 
method to reduce the disease burden of depression and prevent personal 
suffering of patients (Cuijpers, Beekman, & Reynolds, 2012; Muñoz, 
2019). Starting in the late 1980s, a growing number of randomized trials 
have examined the possibilities to prevent the onset of depressive dis-
orders. Several hundreds of studies have examined the effects of pre-
ventive interventions for depression in many different target groups and 
settings (Cuijpers, van Straten, Smit, Mihalopoulos, & Beekman, 2008). 
However, only a limited number of studies have examined the effects of 
preventive interventions on the incidence of new diagnosed depressive 
disorders in those with no depressive disorder at baseline. In the past 25 
years, the number of such trials, in which all participants had a diag-
nostic psychiatric interview to exclude those meeting criteria for a 
depressive disorder at baseline, and another interview to examine the 
incidence of depressive disorders at follow-up, has increased 
considerably. 
There are three types of prevention (Institute of Medicine, 2009). 
Universal prevention is aimed at a whole population, regardless of the 
risk of developing depressive disorders, including for example school 
programs aimed at developing life skills or mass media campaigns. Se-
lective prevention is aimed at high-risk groups, such as children of 
depressed parents, unemployed people, or people who experienced 
trauma recently or in the past. Indicated prevention is aimed at people 
who already have some symptoms, but do not meet criteria for a full- 
blown depressive disorder, this state is often called subthreshold or 
minor depression. These three types of interventions have in common 
that they are aimed at people who do not currently have a depressive 
disorder. Interventions aimed at people who meet criteria for a disorder 
are all in the domain of treatment or maintenance treatment. 
We have previously conducted several earlier meta-analyses of ran-
domized trials aimed at all three types of prevention of depressive dis-
orders (Cuijpers et al., 2008; Van Zoonen et al., 2014), which showed 
that preventive interventions can reduce the incidence of depression 
about 20% compared to no intervention. However, since the last update 
of this meta-analysis (Van Zoonen et al., 2014) a considerable number of 
new trials have been conducted. Including a higher number of studies 
makes it possible to examine the effects of preventive interventions more 
precisely, to examine the impact of bias in these studies and publication 
bias more extensively, and to better examine the effects in specific 
subgroups. Several other meta-analyses in the prevention field have 
been conducted, but these have typically not focused on studies 
excluding participants with a diagnosis at baseline (Hetrick, Cox, Witt, 
Bir, & Merry, 2016; Muñoz, Cuijpers, Smit, Barrera, & Leykin, 2010), or 
have only examined specific subgroups or settings (e.g., Bellón et al., 
2019; Thanhäuser, Lemmer, de Girolamo, & Christiansen, 2017). 
We decided therefore, to conduct a new, comprehensive meta- 
analysis of randomized trials comparing the effects of psychological 
interventions with care-as-usual or comparable control groups in people 
who do not meet criteria for a depressive disorder, and in which these 
interventions were aimed at preventing the onset of depressive disorders 
at follow-up. 
2. Methods 
2.1. Identification and selection of studies 
The protocol for this meta-analysis was registered at the Open Sci-
ence Framework (Cuijpers, Karyotaki, & Ciharova, 2020; Cuijpers, 
Karyotaki, Quero, et al., 2020; Cuijpers, Stringaris, & Wolpert, 2020). To 
identify studies, we used an existing database of randomized trials on 
the psychological treatment of depression. This database has been 
described in detail elsewhere (Cuijpers, Karyotaki, & Ciharova, 2020, 
Cuijpers, Karyotaki, Quero, et al., 2020, Cuijpers, Stringaris, & Wolpert, 
2020), and has been used in a series of earlier published meta-analyses 
(Cuijpers, 2017). The protocol for the current meta-analysis has been 
registered at the Open Science Foundation as part of the main meta- 
analytic project (https://osf.io/p8r52). 
For the meta-analytic database, we searched four major biblio-
graphical databases (PubMed, PsycINFO, Embase, and the Cochrane 
Library) by combining terms (both index terms and text words) indic-
ative of depression and psychotherapies, with filters for randomized 
controlled trials. We also searched a number of bibliographical data-
bases to identify trials in non-Western countries (Cuijpers, Karyotaki, 
Reijnders, Purgato, & Barbui, 2018), because the number of trials on 
psychological treatments in these countries is growing rapidly. 
Furthermore, we checked the references of earlier meta-analyses on 
psychological treatments of depression. The database is continuously 
updated and was developed through a comprehensive literature search 
(from 1966 to 1 January 2020). 
Because in this database only trials on indicated prevention are 
included (aimed at participants who have some symptoms of depression, 
but do not need full diagnostic criteria for a depressive disorder), 
additional searches were conducted in PubMed, PsycINFO and the 
Cochrane database. These searches were aimed to identify randomized 
trials on universal (aimed at whole populations) and selective preven-
tion (aimed at high risk groups). In these searches we combined key 
words and text words for depression, prevention and randomized trials. 
The full search strings for the main database and the additional searches 
are given in Appendix A (PubMed). Deadline for the searches was 
November 14, 2019. In addition, we also checked the references of 
previous meta-analyses of trials on prevention of depressive disorders 
(Bellón et al., 2019; Cuijpers et al., 2008; Hetrick et al., 2016; Loechner 
et al., 2018; Muñoz et al., 2010; Thanhäuser et al., 2017; Van Zoonen 
et al., 2014). 
All records were screened by two independent researchers. All pa-
pers that could possibly meet inclusion criteria according to one of the 
researchers were retrieved as full-text. The decision to include or 
exclude a study in the database was also done by the two independent 
researchers, and disagreements were solved through discussion. 
We included studies meeting the following criteria: (1) participants 
did not meet criteria for current clinical episode of a depressive disorder 
at baseline, as established with a diagnostic interview by a trained 
interviewer or clinician; (2) participants were randomly assigned to a 
psychological preventive intervention or a control group; (3) the inci-
dence in the intervention and control conditions at follow-up (at least 3 
months after randomization) was measured through a diagnostic inter-
view by a trained interviewer or clinician; (4) sufficient data were re-
ported to calculate the incidence rates in the intervention and control 
conditions. Any control group was acceptable, as long as it was defined 
by the researchers as a control group. Studies aimed at relapse preven-
tion, in which all participants were (partly) recovered from depression 
through treatment, were excluded. 
2.2. Quality assessment and data extraction 
We assessed the validity of included studies using four criteria of the 
‘Risk of bias’ assessment tool, developed by the Cochrane Collaboration 
(Higgins et al., 2011). The risk of bias tool assesses possible sources of 
bias in randomized trials, including the adequate generation of alloca-
tion sequence; the concealment of allocation to conditions; the preven-
tion of knowledge of the allocated intervention (masking of assessors); 
and dealing with incomplete outcome data. Assessment of risk of bias 
was conducted by two independent researchers, and disagreements were 
solved through discussion. 
We also coded other characteristics of the studies: type of prevention 
(indicated, selective, universal), target group, time to follow-up (in 
months), proportion of participants with a history of depression, type of 
intervention (cognitive behavior therapy (CBT), interpersonal psycho-
therapy (IPT), other), format of the intervention (individual, group, 
other), number of sessions, country where the study was conducted. 
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2.3. Outcome measures 
Primary outcome was the Relative Risk (RR) of developing a 
depressive disorder at 12 months follow-up or the closest time point to 
12 months follow-up (incidence). Incidence was calculated using an 
‘intention-to-treat approach’. This means that in studies in which 
missing data at follow-up have been imputed, these imputed data were 
used for the calculation of incidence. In studies that have not imputed 
missing data, we considered those who dropped out of the study since 
randomization as new incident cases. 
Secondary outcomes include the RR of developing a depressive dis-
order using completers only data (in which subjects that have dropped 
out of the study are excluded), and acceptability of the interventions 
(defined as study drop-out for any reason). We also calculated the 
number needed to be treated (NNT; Laupacis, Sackett, & Roberts, 1988), 
indicating the number of participants that have to receive the inter-
vention in order to prevent one depressive disorder compared to no 
intervention. The NNT was calculated using the the pooled RR and the 
expected control event rate (the weighted pooled event rate of all the 
control conditions). 
2.4. Meta-analyses 
To calculate pooled RRs, we used the “metafor” package in R and ran 
all analyses in R studio (version 1.1.463 for Mac). Because we expected 
considerable heterogeneity among the studies, we employed a random 
effects model in all analyses. We pooled RRs using the inverse variance 
method, with the Hartung-Knapp adjustment for the random effects 
model. For the assessment of heterogeneity, we calculated I2 and its 95% 
confidence interval (CI), an indicator of heterogeneity in percentages 
(Higgins, Thompson, Deeks, & Altman, 2003). A value of 0% indicates 
no observed heterogeneity, and larger values indicate increasing het-
erogeneity, with 25% as low, 50% as moderate, and 75% as high het-
erogeneity (Higgins et al., 2003). 
We tested for publication bias by inspecting the funnel plot and by 
Duval and Tweedie’s trim and fill procedure (Duval & Tweedie, 2000), 
which yields an estimate of the RR after taking publication bias into 
account. We also conducted Peters’ method to test whether the funnel 
plot is asymmetrical (Peters, Sutton, Jones, Abrams & Rushton, 2006). 
In addition, we calculated the prediction interval, which indicates the 
range in which the true effect size of 95% of future studies will fall 
(Borenstein, Higgins, Hedges, & Rothstein, 2017). 
To examine differences between subgroups of studies, we conducted 
subgroup analyses according to the mixed effects model. In this model 
effect sizes within subgroups are pooled according to the random effects 
model and the difference between subgroups according to a fixed effects 
model. For continuous variables, we used bivariate meta-regression 
analyses to test whether there was a significant relationship between 
the continuous variable and effect size. Multivariate meta-regression 
analyses were conducted, with the effect size as the dependent vari-
able and the predictors from subgroup analyses (as dummy variables) 
and continuous variables. 
Several sensitivity analyses were conducted. First, we included only 
studies with low risk of bias. Second, we excluded studies whose main 
follow-up assessment was outside the range of 6 to 18 months follow-up. 
We did this because the time between randomization and the assessment 
of incidence varied considerably across studies. Third, because only one 
study on universal prevention was included, we also conducted a 
sensitivity analysis in which this study was excluded. Fourth, in some 
studies, more than one psychological intervention was compared with 
the control group. In the main analyses we pooled the outcomes for these 
interventions so that each study had only one effect size. We conducted 
sensitivity analyses in which these studies were excluded. 
3. Results 
3.1. Selection and inclusion of studies 
After examining a total of 5210 abstracts (4085 after removal of 
duplicates), we retrieved 480 full-text papers for further consideration. 
We excluded 430 of the retrieved papers. The PRISMA flowchart 
describing the inclusion process, including the reasons for exclusion, is 
presented in Fig. 1. A total of 50 randomized controlled trials, with 
12,006 participants (6133 in the preventive interventions; 5873 in the 
control conditions) met inclusion criteria for this meta-analysis. Refer-
ences of the trials are given in Appendix B. 
3.2. Characteristics of included studies 
A summary of key characteristics of the included studies are pre-
sented in Table 1. A total of 33 studies examined an indicated preventive 
intervention (66%), 16 were focused on a selective preventive inter-
vention (32%) and one study was focused on universal prevention (2%). 
Twenty-five studies were aimed at adults (50%), 14 on children and 
adolescents (28%) and 11 on older adults (22%). Nine studies were 
aimed at prevention of perinatal depression (18%), 11 were aimed at 
patients with general medical conditions (22%) and 5 were aimed at 
college students (10%). Twenty studies reported the proportion of par-
ticipants who previously had a depressive disorder. In these studies, the 
proportion of participants who previously had a depressive disorder 
ranged from 0.6% to 67% with a median of 34.5%. The mean age of 
participants ranged from 11.4 to 84.4 years of age (median 29.2 years). 
Most interventions (22; 44%) were based on CBT, 8 on IPT (16%), 5 
used a stepped care model (10%), 5 used problem-solving (10%), and 10 
used other types of intervention (20%), such as behavioral activation, 
acceptance and commitment therapy, cognitive bias modification. The 
intervention format was individual in 16 studies (32%), group in 19 
studies (38%) and the other 15 studies used another or a mixed format 
(30%). The number of sessions ranged from 4 to 44 (median 8), but most 
interventions had between 5 and 16 sessions (39 of the 44 studies that 
reported the number of sessions; 88.6%). 
Most studies used a care-as-usual control condition (37; 74%). A total 
of 26 studies were conducted in the US (52%), 17 in Europe (34%) and 7 
in other countries (14%), including Australia (3 studies), China (2 
studies), Canada (1 study) and India (1 study). The risk of bias was 
relatively low in this sample of studies. A total of 41 studies reported an 
adequate sequence generation (82%), 26 studies reported allocation to 
conditions by an independent (third) party (52%), 38 studies reported 
using blinded outcome assessors (76%), and in 40 studies intent-to-treat 
analyses were conducted (80%). A total of 22 studies (44%) met all 
quality criteria, 16 met 2 or 3 criteria (32%), and the remaining 12 
studies met no or only one criterion (24%). Risk of bias of individual 
studies is reported in Table 1 and the overall risk for all studies together 
is reported in Appendix C. 
3.3. Effects of preventive interventions on incidence of depressive 
disorders 
The pooled RR of developing a depressive disorder at 1-year follow- 
up in the preventive interventions was RR = 0.81 (95% CI: 0.72–0.91) 
compared to the control conditions, indicating that the risk of devel-
oping depression was reduced by 19%. The forest plot with the RRs for 
each study are presented in Fig. 2 and the main outcomes are given in 
Table 2. Heterogeneity was low to moderate (I2 = 36%; 95% CI: 9–55). 
The prediction interval ranged from 0.25 to 1.88. 
There was some risk for publication bias. Duval and Tweedie’s trim 
and fill procedure indicated 8 missed studies. The adjusted effect size 
was still significant, however (RR = 0.86; 95% CI: 0.75–0.99). Peters’ 
test of the asymmetry of the funnel plot also pointed as a risk for pub-
lication bias (p = 0.002). The NNT was 18.8. 
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The results of the sensitivity analyses are reported in Table 2. The 
analyses in which only included outcomes measured between 9- and 15- 
months follow-up resulted in outcomes that were very comparable to the 
main analyses. The same was true when the study on universal pre-
vention was excluded and when the studies with multiple intervention 
arms were excluded. In the studies with low risk of bias, the RR was a 
little larger (closer to 1) than the RR found in the main analyses, but the 
RR was no longer significant. This may be related to lower statistical 
power. When outcomes were measured in completers only, the RR was, 
as could be expected, somewhat stronger (RR = 0.64; 95% CI: 
0.56–0.75). Heterogeneity was low to moderate in all analyses. 
We also examined acceptability and the effects of the interventions 
on incidence of depression at the longer term. Acceptability was some-
what better in the control conditions than in the interventions (RR =
1.21; 95% CI: 1.00–1.45) although that was not significant. Heteroge-
neity was moderate in these analyses (I2 = 48; 95% CI: 26–64). At the 
longer term (2–3 years, and 3–8 years) the effects in incidence were no 
longer significant, although the number of studies was small and may 
not have enough statistical power to find significant effects. 
3.4. Subgroup and metaregression analyses 
We conducted a series of subgroup analyses. The results of these 
analyses are reported in Table 3. In the analyses in which type of pre-
vention was examined, we found that both indicated and selective 
prevention had significant effects. Only one study examined the effects 
of universal prevention. The difference between the effects found for the 
three types of prevention were not significant. 
We examined several other subgroups (age groups; specific target 
groups; intervention type; format, care-as-usual versus other control 
groups; country; and risk of bias). None of these subgroup analyses 
indicated significant differences between the effects found in subgroups. 
The only significant difference was for country, where the effects for the 
US were the strongest, also significant effects for Europe, but a much 
Fig. 1. Flowchart of the selection of studies.  
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Table 1 
Selected characteristics of included studies.  
Study Prev 
type 














country ctr RoB SG AC BA ITT 
Albert, 2019 I older adults with 
home care needs 
Older    pst Ind 7 US cau mod + ± + +
Allart, 2007 I Subthreshold 
depression 










Adult 59.4 60.2 0.49 cbm other 44 AUS other low + + + +
Bellon, 2016 S Subthreshold 
depression & high 
risk primary care 
patients 
Adult 34.5 50.7 0.64 sup Ind  SP cau mod ± + + +
Bot, 2019 I adults with 
overweight 





Adult  45.04 0.74 pst + bat 3 6 GER cau low + + + +
Clarke, 2001 I children of 
depressed parents 
Adol 67 14.55 0.64 cbt Group 15 US cau low + + + +
Clarke, 1995 I Subthreshold 
depression 
Adol 38 15.3 0.70 cbt Group 15 US cau high ± ± ± ±
Compas, 
2009 
S children depressed 
parents 
Adol  11.4 0.45 cbt Group 12 US other low + + + +
Cook, 2019 S high on worrying Adult 39.1 20.41 0.83 cbt/cbm 3 6 UK cau low + + + +
De Jonge, 
2009 
S medically ill Adult  52.93 0.58 coll care Ind 8 SWI cau mod + ± + +
Dias, 2019 I older adults Older  69.6 0.63 cbt + pst Ind 6 INDIA cau low + + + +
Dozeman, 
2012 
I older adults in 
residential homes 
Older 54.9 84.4 0.73 stepped 
care 
Ind  NL cau low + + + +
Garber, 
2009 
I children of 
depressed parents 
Adol 55.4 14.8 0.59 cbt Group 14 US cau mod + ± – +
Garcia, 2010 S patients with 
somatoform 
disorders 
Adol  32.3 0.73 cbt Group 5 SP cau low + + + +
Hagan, 2004 S Perinatal Adult 36.2 29.2 1.00 cbt Group 6 AUS cau low + + + +
Joling, 2012 S caregivers 
dementia patients 
Older  69.5 0.70 other mixed 5 NL cau low + + + +
Karp 2019 I Knee 
Osteoarthritis 
Older 33.3 71 0.62 cbt Ind 8 US cau mod + ± + +
Konnert, 
2009 
I nursing home 
residents 
Older  81.1 0.77 cbt Group 13 CAN cau high + ± – – 
Martinovic, 
2006 
I adolescents with 
epilepsy 
Adol  17.4 0.60 cbt Ind 8 SERV cau high + – – ±
Muñoz, 
1995 
S prrimary care 
patients 
Adult  52.4 0.62 cbt Group 8 US cau high ± ± ± ±
Muñoz, 
2007 
I Perinatal Adult 53.7 24.9 1.00 cbt Group 16 US cau high ± + ± – 
Otero, 2015 I caregivers Adult  53.9 73.4 pst Group 5 SP cau low + + + +
Phipps, 
2013 
S Perinatal Adol 16 16 1.00 ipt mixed 5 US other low + + + +
Pols, 2017 I diabetes 2 and 
heart disease 
patients 
Adult  67.5 0.45 stepped 
care 
Ind  NL cau low + + + +
Robinson, 
2008 
I stroke patients Older 5.1 65.6 0.43 pst Ind 12 US other low + + + +
Rohde, 2014 I high school 
students 
Adol  15.5 0.68 cbt mixed  US other mod + – + +
Rohde, 
2014B 
I college students Adult  19 0.70 cbt mixed  US other mod + – + +












Older  84 0.70 bat Ind 6 US other low + + + +
Seligman, 
1999 
S college students at 
risk because of 
attributable style 
Adult   0.52 cbt Group 8 US cau high ± ± + – 
Silverstein, 
2017 
I Head Start 
mothers 
Adult 42.2 31.3 1.00 pst Ind 6 US cau low + + + +
Spence, 
2003 
U students high 
school 
Adol  12.85 0.53 pst + cr Group 8 AUS cau high ± ± – +
I Adol  15.6 0.56 mixed Group 6 US cau mod + – + +
(continued on next page) 
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larger RR for other countries (p < 0.001). 
We also conducted a multivariate meta-regression analysis (Table 4). 
None of the predictors was found to be significantly associated with the 
RR. In order to avoid overfit of the meta-regression model, we repeated 
this meta-regression analysis, with a (manual) stepwise backward 
elimination of the least significant predictor until only significant pre-
dictors remained in the model. This analysis resulted in only one sig-
nificant predictor, namely whether the study was conducted in another 
country than the US or Europe (coefficient: 0.33, SE: 0.15, p = 0.03). The 
RR of studies in these countries was closer to 1. 
4. Discussion 
We identified a considerable number of trials (n = 50) examining the 
effects of psychological intervention on the incidence of new cases of 
depressive disorders at follow-up in people who did not have a depres-
sion at baseline. We found that these interventions can reduce the 
incidence at follow-up by 19%, with an NNT of 15. This remained sig-
nificant in sensitivity analyses and at longer follow-up. 
These findings confirm previous studies showing that it is actually 
possible to prevent the onset of depressive disorders in people who did 
not have such a disorder at baseline (Cuijpers et al., 2008; Van Zoonen 
et al., 2014). This is not true for all participants, but a considerable 
proportion of new disorders can be prevented, which is certainly 
important from a clinical perspective. 
Previous meta-analyses only found significant effects for indicated 
prevention (Cuijpers et al., 2008; Van Zoonen et al., 2014), but in the 
current meta-analysis we also found significant effects for the group of 
selective interventions. Indicated prevention, in those with subthreshold 
depression, can also be seen as early intervention in the prodromal phase 
of those who are already starting to develop the disorder. One could say, 
therefore, that it does not actually prevent the onset of depression, but 
only treats it in the early stages. However, as suggested by the “kindling 
hypothesis” preventing crossing the threshold into a full-blown clinical 
episode of depression may reduce “sensitization” to future stressful life 
events (Monroe & Harkness, 2005). Selective interventions in high risk 
groups, however, are applied in people who do not necessarily already 
have symptoms, and this certainly comes closer to “real” prevention. It is 
possible, however, that participants in selective interventions also have 
subthreshold depression and that it is this group that is responsible for 
the positive effects of the interventions on incidence. 
We found no significant predictors of the effects, only the group of 
studies conducted outside the US and Europe had smaller effects. That 
may reflect a true difference between Western and non-Western coun-
tries, although that is exactly the opposite of what is found for psycho-
logical treatments of depression, which have been found to be more 
effective in non-Western countries (Cuijpers et al., 2018). However, this 
may also very well be an artefact, because of the small number of studies 
in this group, the low statistical power and the relatively large number of 
variables included in the meta-regression analyses. Only three of the 50 
studies in our meta-analysis were conducted in middle income countries, 
two in China (Wong et al., 2018; Zhang et al., 2014) and one in India 
(Dias et al., 2019), and none in low-income countries. Because the ma-
jority of the world population lives in low and middle-income countries 
it is important that future studies examine the possibilities of preventive 
interventions in these settings. 
In order to move the field forward, it is very important to identify 
significant moderators of outcome. Conventional meta-analyses are not 
Table 1 (continued ) 
Study Prev 
type 














country ctr RoB SG AC BA ITT 






S Perinatal Adult  26.13 1.00 cbt Ind 12 US cau mod + ± ± +
Van ‘t Veer, 
2009 
I older primary care 
patients 
Older  81.4 0.74 stepped 
care 
Ind  NL cau low + + + +
VanderAA 
2015 
I visually impaired 
older adults 
Older 20.8 73.7 0.70 stepped 
care 
Ind  NL cau low + + + +
Vazquez, 
2012 
I college students Adult  23.3 0.82 cbt Group 8 SP other high ± + + ±
Willemse, 
2004 
I primary care 
patients 
Adult  40.6 0.66 cbt 3 7 NL cau mod + ± + +
Wong, 2018 I primary care 
patients 
Adult  54 0.93 act+mind Group 8 CHINA cau low + + + +
Young, 2006 I high school 
students 
Adol 4.9 13.5 0.85 ipt mixed 10 US other mod + ± + +
Young, 2010 I high school 
students 
Adol 7 14.5 0.60 ipt mixed 10 US other mod + ± + +
Young, 2016 I high school 
students 
Adol  14.01 0.67 ipt mixed 10 US other mod + ± + +
Zhang, 2014 I primary care 
patients 
Adult  49 0.74 stepped 
care 
Ind  CHINA cau low + + + +
Zlotnick, 
2001 
S Perinatal Adult 0.6 23.4 1.00 ipt Group 4 US cau high ± ± ± +
Zlotnick, 
2006 







Adult  23.8 1.00 ipt mixed 5 US cau mod + + ± +
Zlotnick, 
2016 
S mothers on public 
assistance 
Adult  23 1.00 ipt mixed 5 US cau mod + ± + +
Abbreviations: Prev Type: type of preventive intervention; I: indicated; S: selective; U: Universal; Prop history: Proportion of participants with a history of depressive 
disorder; Prop. Women: Proportion of women; pts.: problem solving therapy; cbt: cognitive-behavioral therapy; cbm: cognitive bias modification; sup: supportive 
intervention; bat: behavioral activation therapy; ipt: interpersonal therapy; act+mind: acceptance and comminment + mindfulness intervention; Ind: Individual 
format; nsess: number of sessions; NL: the Netherlands; ICE: Iceland; AUS: Australia; SP: Spain; EU: Europe; GER: Germany; US: the United States; UK: United Kingdom; 
SWI: Switzerland; CAN; Canada; SERV: Servia; ctr: control group: cau: care-as-usual; RoB: risk of bias; mod: moderate; SG: Sequence generation; AC: Allocation 
concealment; BA: Blinded assessment; ITT: Intention-to-treat analyses. 
P. Cuijpers et al.                                                                                                                                                                                                                                
Clinical Psychology Review 83 (2021) 101955
7
Fig. 2. Forest plot of preventive interventions versus control.  
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well-suited to examine such moderators, because only moderators at the 
study level are available. However, ‘individual participant data’ (IPD) 
meta-analyses combine the primary data of randomized trials and have 
enough statistical power to identify such moderators. One recent IPD 
meta-analysis of indicated prevention of depression found for example 
that the effects of these interventions are stronger when baseline 
severity is higher (Reins et al., 2020). It is also important to consider 
biological risk markers in the further development of the field, although 
until now few markers have a sufficiently strong association to be clin-
ically relevant (Penninx, Milaneschi, Lamers, & Vogelzangs, 2013). 
It is encouraging that psychological interventions do seem to be 
effective in reducing the incidence of depression. Several studies 
examining other interventions have found negative effects, including 
interventions aimed at multinutrient supplements in obese people with 
subthreshold depression (Bot et al., 2019) and vitamin D3 (Okereke 
et al., 2020). These “negative” findings are also highly significant in that 
they illustrate the importance and superiority of large-scale experi-
mental studies over observational studies in depression prevention. 
One matter of concern was that we found that the studies with low 
risk of bias had a comparable effect size, but this was no longer signif-
icant, which may be because of a lack in statistical power. This means 
that the findings still have to be considered with caution and it cannot 
definitely be concluded that preventive interventions are effective. More 
high-quality research is needed to confirm this. 
One issue of concern is that, despite the apparent effects, few pre-
ventive interventions have been integrated into health care systems and 
implementation has been slow. Future research should focus not only on 
efficacy of interventions, but also on how to implement them in routine 
care settings, as this is clearly lagging behind (National Academies of 
Sciences, Engineering, and Medicine, 2019). 
One of the strengths of this study is the relatively large number of 
included trials, their quality and the large number of participants, as 
well as the use of state-of-the-art methods to integrate the results of 
these studies. One important limitation is that participants, in-
terventions and studies are very heterogeneous, and one could doubt 
whether integrating the results of these studies is indeed possible. 
However, all studies share basic characteristics, including inclusion 
criteria, outcome measures and the focus of the interventions on pre-
venting the onset of depression. Furthermore, heterogeneity was small 
to moderate, suggesting that these studies can safely be pooled. Another 
limitation is that in some studies, a considerable number of participants 
had a previous depressive episode. One could argue that these in-
terventions can better be considered prevention of recurrence. However, 
most of the studies reporting the proportion of participants with previ-
ous episodes indicated that this proportion was lower than 50%, indi-
cating that for at least a large part of participants prevention was focused 
on their first episode. Third, the control condition in the majority of the 
included studies was care-as-usual. This implies that the comparison 
cannot pinpoint the specific efficacy of these interventions but may 
reflect only additional attention given to the intervention group. How-
ever, one can also argue that we are particularly interested in this effect 
in order to decide whether an intervention should be added to current 
standard practices. The final limitation is the short follow-up periods. 
Only a handful of studies reported follow-up longer than 2 years. It is 
possible that these interventions did not actually prevent the onset of 
disorders, but only delayed it for some period of time. It should be noted, 
however, that delaying major depressive episodes during a critical 
period could have important positive effects. For example, preventing 
postpartum depression would not only benefit the mother, but would 
also prevent the sequelae of maternal depression as the infant develops. 
Similarly, if adolescent depression could be delayed for even a few years, 
Table 2 
Results of meta-analysis of randomized trials examining interventions aimed at 
preventing the onset of depressive disorders: Relative Risksa.   
Ncomp RR 95% CI I2 95% CI 
Main outcomes      
All studies at FU 50 0.81 0.72–0.91 36 9–55 
Sensitivity analyses      
Adjusted for publication bias 58 0.86 0.75–0.99 41 19–57 
Only low Risk of Bias 22 0.86 0.73–1.02 45 9–67 
Limited to 9–15 months follow- 
up 
29 0.85 0.73–0.98 36 0–59 
Universal prevention excluded 49 0.81 0.72–0.91 37 10–55 
Multiple arms excluded 47 0.81 0.72–0.92 39 12–57 
Completers only 50 0.64 0.56–0.75 28 0–49 
Other outcomes      
Acceptability 40 1.21 1.00–1.45 48 26–64 
Outcome at 2 to 3 years 11 0.85 0.66–1.09 32 0–67 
Outcome at 3 to 8 years 4 0.91 0.74–1.13 0 0–66  
a According to the random effects model. 
Table 3 
Subgroup analyses.  
Subgroups Categories Ncomp RR 95% CI I2 95% CI p  
• Prevention type  → Indicated 33 0.81 0.70–0.94 22 0–49 0.72  
→ Selective 16 0.79 0.64–0.99 56 23–75   
→ Universal 1 1.12 0.50–2.53 – –   
• Age groups  → Children/adolescents 14 0.71 0.51–0.99 25 0–60 0.48  
→ Adults 25 0.81 0.71–0.93 33 0–59   
→ Older adults 11 0.91 0.68–1.22 56 14–78   
• Target group  → Perinatal depression 9 0.73 0.52–1.00 55 5–79 0.31  
→ General medical 11 0.71 0.55–0.93 12 0–53   
→ College students 5 0.93 0.65–1.31 0 0–75   
→ Other 25 0.87 0.74–1.03 34 0–59   
• Intervention  → CBT 22 0.81 0.67–0.98 37 2–62 0.47  
→ IPT 8 0.61 0.37–1.00 8 0–70   
→ Stepped care 5 0.87 0.58–1.30 55 0–83   
→ Other 15 0.87 0.72–1.04 37 0–66   
• Format  → Individual 16 0.77 0.62–0.96 47 6–71 0.81  
→ Group 19 0.84 0.67–1.05 32 0–61   
→ Other/mixed 15 0.83 0.68–1.00 22 0–57   
• Control group  → Care-as-usual 37 0.84 0.74–0.96 43 15–61 0.25  
→ Other 13 0.72 0.56–0.93 9 0–48   
• Country  → US 26 0.72 0.61–0.86 29 0–56 0.001  
→ Europe 17 0.83 0.68–1.00 43 0–68   
→ Other 7 1.06 0.90–1.24 0 0–48   
• Risk of bias  → Low 22 0.86 0.73–1.02 45 9–67 0.08  
→ Moderate 16 0.68 0.57–0.81 0 0–48   
→ High 12 0.90 0.63–1.29 6 0–61   
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young people might be able to successfully navigate key transitions, 
such as graduation from secondary school, completing higher education, 
or starting a career. Having these resources under their belt could reduce 
the impact of clinical depression if they develop an episode later on. 
Despite the limitations mentioned above we can conclude that 
prevention may indeed be an effective approach to reduce the disease 
burden of depression for individuals, their families, and societies. 
Considering the huge disease burden of depression, prevention in-
terventions should be considered a viable option by clinicians and policy 
makers for people experiencing subthreshold symptoms of depression, 
clinicians and policy makers. 
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Appendix A. Full search string for PubMed 
A.1. Search string for the main database of randomized trials on psychological interventions for depression 
(Psychotherapy [MH] OR psychotherap*[All Fields] OR cbt[All Fields] OR "behavior therapies"[All Fields] OR "behavior therapy"[All Fields] OR 
"behavior therapeutic"[All Fields] OR "behavior therapeutical"[All Fields] OR "behavior therapeutics"[All Fields] OR "behavior therapeutist"[all 
Fields] OR "behavior therapeutists"[All Fields] OR "behavior treatment"[All Fields] OR "behavior treatments"[All Fields] OR "behaviors ther-
apies"[All Fields] OR "behaviors therapy"[All Fields] OR "behaviors therapeutics"[All Fields] OR "behaviors therapeutic"[All Fields] OR "behaviors 
therapeutical"[All Fields] OR "behaviors therapeutist"[All Fields] OR "behaviors therapeutists"[All Fields] OR "behaviors treatment"[All Fields] OR 
"behaviors treatments"[All Fields] OR "behavioral therapies"[All Fields] OR "behavioral therapy"[All Fields] OR "behavioral therapeutics"[All 
Fields] OR "behavioral therapeutic"[All Fields] OR "behavioral therapeutical"[All Fields] OR "behavioral therapeutist"[All Fields] OR "behavioral 
therapeutists"[All Fields] OR "behavioral treatment"[All Fields] OR "behavioral treatments"[All Fields] OR "behaviour therapies"[All Fields] OR 
"behaviour therapy"[All Fields] OR "behaviour therapeutic"[All Fields] OR "behaviour therapeutical"[All Fields] OR "behaviour therapeutics"[All 
Fields] OR "behaviour therapeutist"[all Fields] OR "behaviour therapeutists"[All Fields] OR "behaviour treatment"[All Fields] OR "behaviour 
treatments"[All Fields] OR "behaviours therapies"[All Fields] OR "behaviours therapy"[All Fields] OR "behaviours therapeutics"[All Fields] OR 
"behaviours therapeutic"[All Fields] OR "behaviours therapeutical"[All Fields] OR "behaviours therapeutist"[All Fields] OR "behaviours ther-
apeutists"[All Fields] OR "behaviours treatment"[All Fields] OR "behaviours treatments"[All Fields] OR "behavioural therapies"[All Fields] OR 
"behavioural therapy"[All Fields] OR "behavioural therapeutics"[All Fields] OR "behavioural therapeutic"[All Fields] OR "behavioural ther-
apeutical"[All Fields] OR "behavioural therapeutist"[All Fields] OR "behavioural therapeutists"[All Fields] OR "behavioural treatment"[All Fields] 
OR "behavioural treatments"[All Fields] OR "cognition therapies"[All Fields] OR "cognition therapie"[All Fields] OR "cognition therapy"[All Fields] 
OR "cognition therapeutical"[All Fields] OR "cognition therapeutic"[All Fields] OR "cognition therapeutics"[All Fields] OR "cognition ther-
apeutist"[All Fields] OR "cognition therapeutists"[All Fields] OR "cognition treatment"[All Fields] OR "cognition treatments"[All Fields] OR psy-
chodynamic[All Fields] OR Psychoanalysis[MH] OR psychoanalysis[All Fields] OR psychoanalytic*[All Fields] OR counselling[All Fields] OR 
counseling[All Fields] OR Counseling[MH] OR "problem-solving"[All Fields] OR mindfulness[All Fields] OR (acceptance[All Fields] AND 
commitment[All Fields]) OR "assertiveness training"[All Fields] OR "behavior activation"[All Fields] OR "behaviors activation"[All Fields] OR 
"behavioral activation"[All Fields] OR "cognitive therapies"[All Fields] OR "cognitive therapy"[All Fields] OR "cognitive therapeutic"[All Fields] 
OR "cognitive therapeutics"[All Fields] OR "cognitive therapeutical"[All Fields] OR "cognitive therapeutist"[All Fields] OR "cognitive ther-
apeutists"[All Fields] OR "cognitive treatment"[All Fields] OR "cognitive treatments"[All Fields] OR "cognitive restructuring"[All Fields] OR 
(("compassion-focused"[All Fields] OR "compassion-focussed"[All Fields]) AND (therapy[SH] OR therapies[All Fields] OR therapy[All Fields] OR 
therape*[All Fields] OR therapis*[All Fields]OR Therapeutics [OR treatment*[All Fields])) OR ((therapy[SH] OR therapies[All Fields] 
OR therapy [All Fields] OR therape*[All Fields] OR therapis*[All Fields] OR Therapeutics[MH] OR treatment*[All Fields]) AND constructivist* 
[All Fields]) OR "metacognitive therapies"[All Fields] OR "metacognitive therapy"[All Fields] OR "metacognitive therapeutic"[All Fields] OR 
"metacognitive therapeutics"[All Fields] OR "metacognitive therapeutical"[All Fields] OR "metacognitive therapeutist"[All Fields] OR "meta-
cognitive therapeutists"[All Fields] OR "metacognitive treatment"[All Fields] OR "metacognitive treatments"[All Fields] OR "meta-cognitive 
Table 4 
Multivariate meta-regression analyses.  
Subgroups Categories Coeff SE p  
• Indicated vs other types of 
prevention  
− 0.02 0.22 0.92  
• Follow-up (in months; 
continuous)  
− 0.00 0.01 0.89  
• Age groups  → Children/ 
adolescents 
Ref.    
→ Adults − 0.18 0.26 0.48  
→ Older adults 0.32 0.32 0.32  
• Target group  → Perinatal 
depression 
0.11 0.34 0.74  
→ General medical − 0.06 0.33 0.85  
→ College students 0.38 0.41 0.35  
→ Other Ref    
• CBT vs other interventions  − 0.18 0.20 0.38  
• Format  → Individual Ref    
→ Group 0.11 0.30 0.72  
→ Other/mixed 0.18 0.29 0.54  
• Country  → US Ref.    
→ Europe 0.26 0.23 0.26  
→ Other country 0.41 0.27 0.13  
• CAU vs other control group  0.31 0.26 0.24  
• Risk of bias  → (continuous) − 0.07 0.07 0.36  
• Intercept  − 0.53 0.58 0.37  
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therapies"[All Fields] OR "meta-cognitive therapy"[All Fields] OR "meta-cognitive therapeutic"[All Fields] OR "meta-cognitive therapeutics"[All 
Fields] OR "meta-cognitive therapeutical"[All Fields] OR "meta-cognitive therapeutist"[All Fields] OR "meta-cognitive therapeutists"[All Fields] 
OR "meta-cognitive treatment"[All Fields] OR "meta-cognitive treatments"[All Fields] OR "solution-focused therapies"[All Fields] OR "solution- 
focused therapy"[All Fields] OR "solution-focused therapeutic"[All Fields] OR "solution-focused therapeutics"[All Fields] OR "solution-focused 
therapeutical"[All Fields] OR "solution focused therapies"[All Fields] OR "solution focused therapy"[All Fields] OR "solution focused therapeuti-
c"[All Fields] OR "solution focused therapeutics"[All Fields] OR "solution focused therapeutical"[All Fields]OR "solution-focussed therapies"[All 
Fields] OR "solution-focussed therapy"[All Fields] OR "solution-focussed therapeutic"[All Fields] OR "solution-focussed therapeutics"[All Fields] 
OR "solution-focussed therapeutical"[All Fields]OR "solution focussed therapies"[All Fields] OR "solution focussed therapy"[All Fields] OR "so-
lution focussed therapeutic"[All Fields] OR "solution focussed therapeutics"[All Fields] OR "solution focussed therapeutical"[All Fields] OR "self- 
control therapies"[All Fields] OR "self-control therapy"[All Fields] OR "self-control therapeutics"[All Fields] OR "self-control therapeutical"[All 
Fields] OR "self-control therapeutic"[All Fields] OR "self-control training"[All Fields] OR "self-control trainings"[All Fields] OR "self control 
therapies"[All Fields] OR "self control therapy"[All Fields] OR "self control therapeutics"[All Fields] OR "self control therapeutical"[All Fields] OR 
"self control therapeutic"[All Fields] OR "self control training"[All Fields] OR "self control trainings"[All Fields] AND (Depressive Disorder[MH] OR 
Depression[MH]OR dysthymi*[All Fields] OR "affective disorder"[All Fields]OR "affective disorders"[All Fields] OR "mood disorder"[All Fields] 
OR "mood disorders"[All Fields] OR depression*[All Fields] OR depressive*[All Fields] OR "dysthymic disorder"[MeSH Terms]) AND ((randomized 
controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR randomly [tiab] NOT (animals[mh] NOT (animals[mh] AND humans 
[mh])) 
A.2. Search string for additional searches for universal and selective prevention 
The full search string for PubMed for these additional searches is: (("depressive disorder"[MeSH Terms] OR ("depressive"[All Fields] AND "dis-
order"[All Fields]) OR "depressive disorder"[All Fields] OR "depression"[All Fields] OR "depression"[MeSH Terms]) OR depressive[All Fields]) AND 
(("prevention and control"[Subheading] OR ("prevention"[All Fields] AND "control"[All Fields]) OR "prevention and control"[All Fields] OR "pre-
vention"[All Fields]) OR preventive[All Fields]) AND Randomized Controlled Trial[ptyp] 
Appendix B. References of the included studies 
B.1. References of primary studies 
Albert, S. M. et al. Depression agency-based collaborative: Effect of problem-solving therapy on risk of common mental disorders in older adults 
with home care needs. The American Journal of Geriatric Psychiatry 27, 619–624 (2019). 
Allart-van Dam, E., Hosman, C. M. H., Hoogduin, C. A. L. & Schaap, C. P. D. R. Prevention of depression in subclinically depressed adults: Follow-up 
effects on the ‘Coping with Depression’ course. Journal of Affective Disorders 97, 219–228 (2007). 
Arnarson, E. Ö. & Craighead, W. E. Prevention of depression among Icelandic adolescents. Behavior Research and Therapy 47, 577–585 (2009). 
Basanovic, J. et al. Cognitive bias modification to prevent depression (COPE): Results of a randomized controlled trial. Psychological medicine 1–12 
(2019) doi:https://doi.org/10.1017/S0033291719002599 
Bellon, J. A. et al. Intervention to prevent major depression in primary care: A cluster randomized trial. Ann Intern Med 164, 656–665 (2016). 
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López, L. et al. Problem-solving intervention to prevent depression in non-professional caregivers: A randomized controlled trial with 8 years of 
follow-up. Psychological Medicine (2019) doi:https://doi.org/10.1017/S0033291719000916 
Pols, A. et al. Two-year effectiveness of a stepped-care depression prevention intervention and predictors of incident depression in primary care 
patients with diabetes type 2 and/or coronary heart disease and subthreshold depression: Data from the Step-Dep cluster randomized controlled trial. 
BMJ open 8, (2018). 
Rohde, P., Stice, E. & Gau Jeff, M. Effects of three depression prevention interventions on risk for depressive disorder onset in the context of 
depression risk factors. Prevention science 13, 584–593 (2012). 
van Schaik, D. J. F. et al. Preventing depression in homes for older adults: Are effects sustained over 2 years? Int J Geriatr Psychiatry 29, 191–197 
(2014). 
Van ‘t Veer-Tazelaar PJ, van Marwijk HWJ, van Oppen P, van der Horst HE, Smit F, Cuijpers P, Beekman ATF (2011). Prevention of late-life anxiety 
and depression has sustained effects over 24 months: A pragmatic randomized trial. American Journal of Geriatric Psychiatry 19, 230–239. 
Young, J. F. et al. Long-term effects from a school-based trial comparing interpersonal psychotherapy-adolescent skills training to group coun-
seling. Journal of Clinical Child and Adolescent Psychology 48, S362–S370 (2019). 
Appendix C. Risk of bias in the included studies 




Blinding of outcome assessors
Intention to treat analyses
Low risk of bias
Moderate risk of bias
High risk of bias
References 
Andrews, G., Issikadis, C., Sanderson, K., Corry, J., & Lapsley, H. (2004). Utilising survey 
data to informpublic policy: Comparison of the cost-effectiveness of treatment of 
tenmental disorders. British Journal of Psychiatry, 184, 526–533. 
Barth, J., Munder, T., Gerger, H., Nüesch, E., Trelle, S., Znoj, H., … Cuijpers, P. (2013). 
Comparative efficacy of seven psychotherapeutic interventions for patients with 
depression: A network meta-analysis. PLoS Medicine, 10, Article e1001454. 
Bellón, J. A., Conejo-Cerón, S., Cortés-Abela, C., Pena-Andreu, J. M., García- 
Rodríguez, A., & Moreno-Peral, P. (2019). Effectiveness of psychological and 
educational interventions for the prevention of depression in the workplace: A 
systematic review and meta-analysis. Scandinavian Journal of Work, Environment & 
Health, 45, 324–332. 
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Thanhäuser, M., Lemmer, G., de Girolamo, G., & Christiansen, H. (2017). Do preventive 
interventions for children of mentally ill parents work? Results of a systematic 
review and meta-analysis. Current Opinion in Psychiatry, 30, 283–299. 
Van Zoonen, K., Buntrock, C., Ebert, D. D., Smit, F., Reynolds, C. F., Beekman, A. T. F., & 
Cuijpers, P. (2014). Preventing the onset of major depressive disorder: A meta- 
analytic review of psychological interventions. International Journal of Epidemiology, 
43, 318–329. 
Wong, S. Y. S., Sun, Y. Y., Chan, A. T. Y., Leung, M. K. W., Chao, D. V. K., Li, C. C. K., et al. 
(2018). Treating subthreshold depression in primary care: A randomized controlled 
trial of behavioral activation with mindfulness. Annals of Family Medicine, 16, 
111–119. 
World Health Organisation. (2017). Depression and other common mental disorders: Global 
health estimates. Geneva: World Health Organization, 2017. Licence: CC BY-NC-SA 
3.0 IGO. 
Zhang, D. X., Lewis, G., Araya, R., Tang, W. K., Mak, W. W. S., Cheung, F. M. C. C., et al. 
(2014). Prevention of anxiety and depression in Chinese: A randomized clinical trial 
testing the effectiveness of a stepped care program in primary care. Journal of 
Affective Disorders, 169, 212–220. 
P. Cuijpers et al.                                                                                                                                                                                                                                
